V
Velarion™Intelligence
Sign InFree TrialBook a Walkthrough
MedTech & Diagnostics

DexCom Executive Compensation (FY25)

DXCM · Executive and director compensation, fiscal 2022 to 2025
Chief executive, fiscal 2025
◇
Jacob Leach
Median of the other named officers
$6,745,295
5 officers, excluding the chief executive
Latest say-on-pay support
=
May 27, 2026
Chief executive pay ratio
◇
To the median employee
Velarion Member: every covered company in MedTech & Diagnostics, with dashboards, peer screens and board-ready briefs. Three seats, one year.

The DexCom brief, $1,500

Positioning against its disclosed peers, the governance read, incentive design, and the CD&A alignment analysis; the full peer table; a committee-ready PDF.
Both reports for $2,400.
Get the executive briefGet the board briefNo account needed.
Data as of October 22, 2026Latest filing (8-K): May 28, 2026
12 filings cited on this page
A report that fails to generate is refunded in full
Published by Velarion Company Intelligence
DexCom brief$1,500Get the executive brief
Velarion Member, one year
264 figures on this page: 256 cited to the filing that reported them, 8 calculated from figures it prints. See the citations
What changed from fiscal 2024 to fiscal 2025
The figures that moved, and by how much. Analysis of these figures is part of the Velarion platform.
Chief executive total compensation — Jacob Leach: $5,922,271 → $7,985,960 (34.8% higher)
Say-on-pay support: 89.6% → 88.3% (1.3 points lower)
CEO pay ratio: 139:1 → 278:1 (100.0% higher)

Frequently asked questions

Answers drawn from the data on this page.
Who is DexCom's chief executive and what were they paid?
Jacob Leach was paid $7,985,960 in total compensation as President & Chief Executive Officer for fiscal 2025. Leach's total was 34.8% higher than the $5,922,271 reported for fiscal 2024.
What was DexCom's say-on-pay result?
For fiscal 2025, shareholders backed the say-on-pay proposal with 88.3% of votes cast for or against in favor at the meeting held May 27, 2026.
Which companies are in DexCom's peer group?
The disclosed peer group includes Agilent Technologies, Inc., Align Technology, Inc., Amgen Inc., BioMarin Pharmaceutical Inc. and Boston Scientific Corporation, among others.
What is DexCom's chief executive pay ratio?
The company reported a chief executive pay ratio of 278:1 for fiscal 2025, against median employee compensation of $58,663.

Executive compensation

Every element reported for each named executive officer, by fiscal year.
Fiscal 2022
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Kevin Sayer
Chairperson, President & Chief Executive Officer
◇—◇—◇—◇◇
Michael Brown
EVP, Chief Legal Officer
◇—◇—◇—◇◇
Jacob Leach
EVP, Chief Operating Officer
◇—◇—◇—◇◇
Girish Naganathan
EVP, Chief Technology Officer
◇◇◇—◇—◇◇
Jereme Sylvain
EVP, Chief Financial Officer
◇—◇—◇—◇◇
Fiscal 2023
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Kevin Sayer
Chairperson, President & Chief Executive Officer
◇—◇—◇—◇◇
Teri Lawver
EVP, Chief Commercial Officer
◇◇◇—◇—◇◇
Jacob Leach
EVP, Chief Operating Officer
◇—◇—◇—◇◇
Michael Brown
EVP, Chief Legal Officer
◇—◇—◇—◇◇
Jereme Sylvain
EVP, Chief Financial Officer
◇—◇—◇—◇◇
Fiscal 2024
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Kevin Sayer
Executive Chairman
◇—◇———◇◇
Teri Lawver
Former EVP, Chief Commercial Officer
Departed during or after this year
◇◇◇———◇◇
Jacob Leach
President & Chief Executive Officer
◇—◇———◇◇
Jereme Sylvain
EVP, Chief Financial Officer
◇—◇———◇◇
Michael Brown
EVP, Chief Legal Officer
◇—◇———◇◇
Sadie Stern
EVP, Chief Human Resources Officer
◇—◇———◇◇
Fiscal 2025
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Kevin Sayer
Executive Chairman
◇—◇—◇—◇◇
Jacob Leach
President & Chief Executive Officer
◇—◇—◇—◇◇
Jereme Sylvain
EVP, Chief Financial Officer
◇—◇—◇—◇◇
Jon Coleman
EVP, Chief Commercial Officer
◇—◇—◇—◇◇
Michael Brown
EVP, Chief Legal Officer
◇—◇—◇—◇◇
Sadie Stern
EVP, Chief Human Resources Officer
◇—◇—◇—◇◇
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. A negative change in pension value is shown but, as the company reports it, not included in the total.

Equity awards granted

Individual awards as disclosed: type, date, unit counts at each level, and grant date value.
Fiscal 2025
OfficerAwardGrant dateThreshold unitsTarget unitsUnits grantedMaximum unitsExercise priceGrant date fair value
Jacob LeachRSU◇——◇——◇
Jacob LeachRSU◇——◇——◇
Jereme SylvainRSU◇——◇——◇
Jereme SylvainRSU◇——◇——◇
Kevin SayerRSU◇——◇——◇
Michael BrownRSU◇——◇——◇
Michael BrownRSU◇——◇——◇
Sadie SternRSU◇——◇——◇
Sadie SternRSU◇——◇——◇
Fiscal 2022, 2023 are included in the PDF.
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. Threshold, target and maximum apply only to performance awards and are never shown for time-based or option awards.

Outstanding awards

Awards still held at fiscal year end.
As disclosed at fiscal 2025 year end
OfficerAwardUnvested unitsMarket value of unvested unitsExercise priceExpires
Jereme SylvainRSU◇◇——
RSU◇◇——
RSU◇◇——
RSU◇◇——
PSU◇◇——
RSU◇◇——
RSU◇◇——
RSU◇◇——
Jacob LeachPSU◇◇——
RSU◇◇——
RSU◇◇——
RSU◇◇——
RSU◇◇——
RSU◇◇——
RSU◇◇——
RSU◇◇——
Michael BrownRSU◇◇——
RSU◇◇——
RSU◇◇——
PSU◇◇——
RSU◇◇——
RSU◇◇——
RSU◇◇——
RSU◇◇——
RSU◇◇——
Kevin SayerPSU◇◇——
RSU◇◇——
RSU◇◇——
RSU◇◇——
RSU◇◇——
Sadie SternRSU◇◇——
PSU◇◇——
RSU◇◇——
RSU◇◇——
RSU◇◇——
RSU◇◇——
RSU◇◇——
RSU◇◇——
Jon ColemanRSU◇◇——
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.

Director compensation

What each non-employee director was paid.
Fiscal 2025
DirectorFees earned in cashStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Bridgette Heller
—◇—————
Rimma Driscoll
—◇—————
Steven Altman
—◇—————
Richard Collins
—◇—————
Nicholas Augustinos
—◇—————
Mark Foletta
Lead independent director
—◇—————
Kyle Malady
—◇—————
Euan Ashley
—◇—————
Renée Galá
—◇—————
Kevin Sayer, Rick Osterloh, Karen Dahut, Eric Topol and Jacob Leach served on the board in fiscal 2025 and received no compensation for board service. Executive directors are typically paid through their executive roles, shown above.
Earlier years are included in the PDF.
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.

Director fee schedule

The standing retainers and premiums the board pays, as published.
Board equity retainer◇
Lead independent director premium◇
Audit committee chair◇
Audit committee member◇
Compensation committee chair◇
Compensation committee member◇
Nominating and governance chair◇
Nominating and governance member◇
Equity is delivered as restricted stock units.

Disclosed peer group

The companies this board named as its compensation comparison group. The list is disclosure; the comparison is analysis.
Fiscal 2025
  • Agilent Technologies, Inc. A
  • Align Technology, Inc. ALGN
  • Amgen Inc. AMGN
  • BioMarin Pharmaceutical Inc. BMRN
  • Boston Scientific Corporation BSX
  • Docusign, Inc. DOCU
  • Edwards Lifesciences Corporation EW
  • Exact Sciences Corporation EXAS
  • Hologic, Inc. HOLX
  • IDEXX Laboratories, Inc. IDXX
  • Illumina, Inc. ILMN
  • Insulet Corporation PODD
  • Intuitive Surgical, Inc. ISRG
  • Moderna, Inc. MRNA
  • ResMed Inc. RMD
  • Veeva Systems Inc. VEEV
  • Workday, Inc. WDAY
  • Zimmer Biomet Holdings, Inc. ZBH

Say-on-pay history

Shareholder support for the compensation program, by year.
YearMeetingSupportVotes forVotes againstAbstentions
2025May 27, 2026=◇◇◇
2024May 8, 2025=◇◇◇
2023May 22, 2024=◇◇◇
2022May 18, 2023=◇◇◇
2021May 19, 2022=◇◇◇
2020May 20, 2021=◇◇◇
2019May 21, 2020=◇◇◇
2018May 30, 2019=◇◇◇

Chief executive pay ratio

As calculated and reported by the company.
Ratio
◇
Median employee compensation
◇
Chief executive total compensation
◇

Velarion Pro: every company page, peer tools and exports, one seat

One seat, one person. It opens the whole platform: the peer tools, the written analysis and the exports, on every company we cover. Join the list and you will hear from us when it opens.
Your address is used for this and nothing else, and you can unsubscribe in one click. See the privacy policy.

Ask our research desk — $99, 24h, every figure cited to its filing.

Sample answer — “What is the CEO’s total compensation?”
- Jacob Leach (President & Chief Executive Officer), FY2025 total compensation $7,985,960 (base salary $768,962) [exec_comp, SEC accession 0001093557-26-000061, filed 2026-04-15]

Answered within 24 hours, every figure cited to its SEC filing. If our database cannot answer your question, you are refunded automatically.

Email me this page as a cited PDF — sent in 2 minutes
The same figures, the same citations, formatted to hand to a committee. Nothing is added that is not on this page.
Your address is used for this and nothing else. Unsubscribe in one click.
Tell me when DexCom files
You get a note when this company’s compensation data changes.
Your address is used for this and nothing else. Unsubscribe in one click.

What this page does not include

Everything above is a fact DexCom disclosed, and it is free. Everything below is our analysis of those facts, and it is not.
Peer benchmarking
Where DexCom sits against its disclosed peers — percentile position by role and by pay element, and the ranking behind it. The disclosed peer group is free; comparisons across it are part of the Velarion platform.
Executive Compensation Report — $1,500
Written compensation analysis
A read of the pay program as designed and as paid: incentive structure, goal rigor, the alignment between the committee's stated philosophy and what the numbers show.
Executive Compensation Report — $1,500
Board and governance analysis
Committee composition, independence, director pay positioning, and the governance provisions read together rather than listed.
Board Governance Report — $499
Realizable pay
What the awards above are actually worth today against what they were valued at on grant, and what the gap says about the pay-for-performance link.
Velarion Intelligence
Adviser switching and vote outcomes
Two datasets covering compensation-adviser changes and what followed a contested vote. Both are part of the Velarion platform.
Inquire about access
Multiple companies at once
Cross-company views, cohort screens, and data export across the industries we cover. This page is one company; the platform is all of them.
Velarion Intelligence
Join the list for Peer Group Review
Whether DexCom's disclosed peer group is defensible, who names DexCom back in their own benchmarking group, and how pay tracks performance across it. This is the analysis a compensation consultant delivers on the group above. We will email you when it opens.
Your address is used for this and nothing else. Unsubscribe in one click.

Citations

Every figure on this page is cited to the document that reported it. Select any figure to see its citation.
264 figures on this page: 256 cited to the filing that reported them, 8 calculated from figures it prints.
256 cited to the filing
8 calculated from the filing

Documents cited

  1. 0001093557-26-000105
    ITEM 5.07. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS.
  2. 0001093557-26-000061
    2025 Director Compensation Table · 2025 Summary Compensation Table · Grants of Plan-Based Awards for 2025 · NON-EMPLOYEE DIRECTOR COMPENSATION · and 2 more sections
  3. 0001093557-25-000129
    ITEM 5.07. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS.
  4. 0001093557-25-000100
    2024 Summary Compensation Table
  5. 0001093557-24-000101
    Item 5.07 Submission of Matters to a Vote of Security Holders
  6. 0001093557-24-000070
    2023 Summary Compensation Table
  7. 0001193125-23-149463
    Item 5.07 Submission of Matters to a Vote of Security Holders
  8. 0001093557-23-000099
  9. 0001193125-22-155671
    Item 5.07 Submission of Matters to a Vote of Security Holders
  10. 0001193125-21-169442
    Item 5.07 Submission of Matters to a Vote of Security Holders
  11. 0001193125-20-150279
    Item 5.07 Submission of Matters to a Vote of Security Holders
  12. 0001093557-19-000137
    Item 5.07 Submission of Matters to a Vote of Security Holders
Cite this data
This page is free to cite. Attribution we ask for:
Velarion, “DexCom executive compensation, FY2022–FY2025.” https://intel.velarion.ai/comp/DXCM (accessed 2026).
Short form: data: Velarion

The DexCom brief, $1,500

Positioning against its disclosed peers, the governance read, incentive design, and the CD&A alignment analysis; the full peer table; a committee-ready PDF.
Both reports for $2,400.
Get the executive briefGet the board briefNo account needed.
12 filings cited on this page
Method: intel.velarion.ai/methodology
A report that fails to generate is refunded in full
Published by Velarion Company Intelligence
Embed this data
A small, cited view of this data for your own page or newsletter. Every embed carries a visible link back here, so the attribution travels with it.
The headline figures, each with its citation.
Connect an AI assistant
Ask your own assistant about DexCom and roughly 3,000 other US public companies, and get back the same figures on this page with the same citations. Free read access, no account. Add this to your assistant's connector settings.
Setup guide and the full list of questions it answers

MedTech & Diagnostics rankings

Chief executive pay — MedTech & DiagnosticsCEO pay ratio — MedTech & DiagnosticsSay-on-pay support — MedTech & Diagnostics

Peers DexCom discloses

The companies named in DXCM's own disclosed peer group.

Agilent Technologies, Inc.Align Technology, Inc.Amgen Inc.BioMarin Pharmaceutical Inc.Boston Scientific CorporationDocusign, Inc.Edwards Lifesciences CorporationExact Sciences CorporationHologic, Inc.IDEXX Laboratories, Inc.Illumina, Inc.Insulet CorporationIntuitive Surgical, Inc.Moderna, Inc.ResMed Inc.Veeva Systems Inc.Workday, Inc.Zimmer Biomet Holdings, Inc.

Terms on this page

Say-on-Pay VoteCEO Pay RatioMedian Employee CompensationAll companies

Free to read and cite. Redistribution or bulk use of the dataset requires a data license. Talk to us about the data license.

Cite this data
APA
Velarion Company Intelligence. (2026). Velarion database: executive and board compensation data (Version 2026Q3) [Data set]. Zenodo. https://doi.org/10.5281/zenodo.22283854
BibTeX
@misc{velarionData2026,
  author = {{Velarion Company Intelligence}},
  title = {Velarion database: executive and board compensation data},
  year = {2026},
  version = {2026Q3},
  doi = {10.5281/zenodo.22283854},
  publisher = {Zenodo},
  url = {https://doi.org/10.5281/zenodo.22283854}
}
For informational purposes only. Not investment, legal, or compensation advice.  All companies · The Pay Desk · Methodology · Terms · Privacy